Is BioGaia AB (publ) (BIOGY) a Buy, Sell, or Hold?
OTC : BIOGY
BioGaia AB (publ)
$12.2 USD
$2.41 (24.62%)
- Volume
- 1
- Average Volume
- 122
- Market Capitalization
- $1.23B
- P/E Ratio
- 33.67
- Dividend Yield
- 3.46%
- Price Target
- Year High
- $12.20
- Year Low
- $8.79
- Day High
- —
- Day Low
- —
- Payout Ratio
- $1.17
- Current Ratio
- $4.44
Company Overview
OTC
Theresa Agnew
Drug Manufacturers - Specialty & Generic
Healthcare
BIOGY
243
SE
USD
Liquidity Metrics
0.00
4.44
4.44
2.11
1.17
Sales & Valuation
$1.54B
7.20
10.61
37.96
2.96
Profitability
$3.29
$332.76M
21.97%
28.12%
27.58%
25.98%
P/E Metrics
33.67
1.59
1.59
Analyst Price Target & Rating
3/5
0 Analysts
%
Financial Health Scores
33.56
5/9
$728.98M
$1.34B
$235.14M
$449.01M
Key Metrics (TTM)
$10.78B
6.82
23.15
4.44
27.58%
30.38%
3.01%
2.67%
$28.99
0 days
Company Executives
| Name | Title |
|---|---|
| Gianfranco Grompone | Chief Scentific Officer |
| Angelika Kjelldorff | Chief Human Resources Officer |
| Caroline Mofors | Executive Vice President & Chief Legal Officer |
| Alexander Kotsinas | Executive Vice President & Chief Financial Officer |
| Darryl Mallette | Managing Director Canada |
| Jennifer Cherry | Managing Director USA |
| Minna Tähtinen | Managing Director Finland |
| Linda Hagglund | Chief Marketing Officer |
| Theresa Agnew | Chief Executive Officer & President |
| Ludvig Milesson | Chief Operating Officer |
Poll Results
No votes yet today — be the first to share your view!
About BioGaia AB (publ) (OTC:BIOGY) Stock
BioGaia AB (publ) is a global enterprise dedicated to the development, marketing, and sale of probiotic products, all backed by documented health benefits. The company organizes its activities into three primary divisions: Pediatrics, Adult Health, and 'Other'. Within the Pediatric segment, BioGaia provides items such as liquid drops, oral rehydration solutions, and gut health tablets, alongside supplying probiotic cultures for integration into infant formula. The Adult Health segment offers both digestive health tablets and oral hygiene lozenges, as well as providing cultures that are incorporated into dairy products by its licensees. The 'Other' segment focuses on delivering packaging solutions. BioGaia's product portfolio addresses a wide array of health conditions, including infantile ... colic and digestive problems in children, acute and antibiotic-associated diarrhea, gingivitis, periodontal disease, general wellness, Helicobacter pylori infections (the bacterium causing gastric ulcers), and low bone density. All of the company's products are sold under the BioGaia brand. Founded in 1990, BioGaia AB (publ) is headquartered in Stockholm, Sweden.
BioGaia AB (publ) (BIOGY) Q2 2026 Earnings Call Transcript
2026-07-17 14:46:16
BioGaia AB (publ) (BIOGY) Q2 2026 Earnings Call Transcript
Frequently Asked Questions
-
What is the current BioGaia AB (publ) (BIOGY) stock price?
-
BioGaia AB (publ)(OTC:BIOGY) stock price is $12.2 in the last trading session. During the trading session, BIOGY stock reached the peak price of $12.2 while $8.79 was the lowest point it dropped to. The percentage change in BIOGY stock occurred in the recent session was 24.62% while the dollar amount for the price change in BIOGY stock was $2.41.
-
BIOGY's industry and sector of operation?
-
The OTC listed BIOGY is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector.
-
Who are the executives of BIOGY?
-
Gianfranco Grompone | Chief Scentific Officer
Angelika Kjelldorff | Chief Human Resources Officer
Caroline Mofors | Executive Vice President & Chief Legal Officer
Alexander Kotsinas | Executive Vice President & Chief Financial Officer
Darryl Mallette | Managing Director Canada -
How many employees does BIOGY have?
-
Number of BIOGY employees currently stands at 243. BIOGY operates from Kungsbroplan 3, Stockholm, AB 112 27, SE.
-
Link for BIOGY official website?
-
Official Website of BIOGY is: https://www.biogaiagroup.com
-
How do I contact BIOGY?
-
BIOGY could be contacted at phone #46 8 55 52 93 00 and can also be accessed through its website. BIOGY operates from Kungsbroplan 3, Stockholm, AB 112 27, SE.
-
How many shares of BIOGY are traded daily?
-
The average number of BIOGY shares traded daily for last 3 months was 122.
-
What is the market cap of BIOGY currently?
-
The market value of BIOGY currently stands at $1.23B with its latest stock price at $12.2